Limited HIV-1 Subtype C nef 3′PPT Variation in Combination Antiretroviral Therapy Naïve and Experienced People Living with HIV in Botswana

Dolutegravir (DTG) is a potent anti-HIV drug that is used to treat HIV globally. There have been reports of mutations in the HIV-1 3′-polypurine tract (3′PPT) of the nef gene, contributing to DTG failure; however, there are limited ‘real-world’ data on this. In addition, there is a knowledge gap on...

Descripción completa

Detalles Bibliográficos
Autores principales: Seatla, Kaelo K., Maruapula, Dorcas, Choga, Wonderful T., Morerinyane, Olorato, Lockman, Shahin, Novitsky, Vladimir, Kasvosve, Ishmael, Moyo, Sikhulile, Gaseitsiwe, Simani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400509/
https://www.ncbi.nlm.nih.gov/pubmed/34451492
http://dx.doi.org/10.3390/pathogens10081027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400509/
https://www.ncbi.nlm.nih.gov/pubmed/34451492
http://dx.doi.org/10.3390/pathogens10081027

Ejemplares similares